Clinical economics review: gastrointestinal complications of non-steroidal anti-inflammatory drugs (Q39445927)

12 September 2017

Clinical economics review: gastrointestinal complications of non-steroidal anti-inflammatory drugs (English)

1 reference

12 September 2017

0 references

Haslock I

1

1 reference

PubMed ID

9692686

12 September 2017

language of work or name

English

0 references

publication date

1 February 1998

1 reference

Alimentary Pharmacology & Therapeutics

12 September 2017

1 reference

12 September 2017

12

1 reference

12 September 2017

2

1 reference

12 September 2017

127-133

1 reference

Non-steroidal anti-inflammatory drug usage and requirement in elderly acute hospital admissions.

12 September 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00287.X

An Account of the Success of the Bark of the Willow in the Cure of Agues. In a Letter to the Right Honourable George Earl of Macclesfield, President of R. S. from the Rev. Mr. Edmund Stone, of Chipping-Norton in Oxfordshire

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00287.X

The Use of Aspirin in Ischemic Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00287.X

Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00287.X

Non-steroidal anti-inflammatory drugs and pain free peptic ulceration in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00287.X

Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00287.X

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00287.X

Enteroscopic diagnosis of small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00287.X

Nonsteroidal antiinflammatory drugs and human cancer. Report of an interdisciplinary research workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00287.X

Analgesic efficacy and safety of paracetamol-codeine combinations versus paracetamol alone: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00287.X

Excess costs from gastrointestinal disease associated with nonsteroidal anti-inflammatory drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00287.X

Topical non-steroidal anti-inflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: a record linkage case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00287.X

Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00287.X

Safety experience with nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00287.X

Effect of a prior-authorization requirement on the use of nonsteroidal antiinflammatory drugs by Medicaid patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00287.X

Economic effects of prophylactic use of misoprostol to prevent gastric ulcer in patients taking nonsteroidal anti-inflammatory drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00287.X

Economic evaluation of gastric ulcer prophylaxis in patients with arthritis receiving non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00287.X

The cost-effectiveness of misoprostol for nonsteroidal antiinflammatory drug-associated adverse gastrointestinal events

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00287.X

Is misoprostol cost-effective in the prevention of nonsteroidal anti-inflammatory drug-induced gastropathy in patients with chronic arthritis? A review of conflicting economic evaluations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00287.X

Thromboxane and Prostacyclin Metabolites in Pulmonary Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1998.00287.X

10.1046/J.1365-2036.1998.00287.X

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference

PubMed ID

9692686